LONDON, Nov. 10, 2016 /PRNewswire/ — Bone marrow transplant or hematopoietic stem cell transplant is the surgical procedure to replace impaired bone marrow tissue or bone marrow stem cells with healthy ones. Bone marrow transplant procedure is recommended to treat severe stages of leukemia, Hodgkin and non-Hodgkin lymphomas, multiple myeloma, aplastic and sickle cell anemia, thalassemia etc. As per transplant activity report 2009-2013 from the Center for International Bone and Marrow Transplant Research (CIBMTR), of a total of 88,063 bone marrow transplant procedures performed in the U.S., over 57% procedures were autologous bone marrow transplant procedures.
The report covers the global bone marrow transplant market performance in terms of volume (procedural count) and revenue contribution. The report includes key trends, drivers, restraints, and opportunities influencing the growth of the global bone marrow transplant market over the forecast period. Impact analysis of key growth drivers and restraints, based on the
... read more at: http://www.satprnews.com/page/45850/